McKesson Corporation

MCK Healthcare Medical Distribution

McKesson Corporation’s revenue for fiscal 2026 (year ended March 2026) was $403.4 billion, up 12.4% from fiscal 2025.

Revenue
+7.57%
EPS
+17.0%
Free cash flow
+32.5%
Total debt
+7.08%

Quarter to September 2026, against a year earlier

1,061.69 10.31 −0.96%
Market cap
$125.0B
P/E
27.5×
Fwd P/E
25.4×
Dividend yield
0.32%
F-score
7/9
Altman Z
6.15
Beneish M
−2.34
Dividend safety
86/100
Mar '17 Mar '18 Mar '19 Mar '20 Mar '21 Mar '22 Mar '23 Mar '24 Mar '25 Mar '26
Piotroski F-Score
4 6 7 7 4 7 7 5 6 7
P/E ratio
6.29 607.87 1,485.50 26.06 0.00 41.94 14.13 23.81 25.92 22.40
Altman Z-Score
4.37 4.15 4.22 4.46 3.90 4.86 5.35 5.63 5.88 6.15
P/S ratio
0.17 0.14 0.11 0.11 0.13 0.18 0.18 0.23 0.24 0.27
Altman Z″-Score (non-manufacturers)
1.87 1.04 1.04 1.02 0.02 0.42 0.71 0.66 0.61 0.59
P/FCF ratio
7.83 7.72 6.71 6.32 8.03 11.96 10.92 19.70 16.41 19.77
P/Operating CF
22.83 9.62 5.99 5.25 9.29 16.15 15.11 17.23 11.07 31.27
Beneish M-Score
(2.29) (2.86) (2.81) (2.60) (3.19) (2.78) (2.38) (2.42) (2.42) (2.34)
Dividend Safety Score
— — — — — — — — — 86
P/B ratio
2.91 2.89 2.82 4.60 178.99 0.00 0.00 0.00 0.00 0.00
EV/Sales
0.19 0.16 0.13 0.12 0.17 0.21 0.21 0.25 0.25 0.28
EV/EBITDA
4.63 8.72 7.14 7.83 0.00 20.08 11.58 17.30 18.05 16.51
EV/FCF
9.21 9.11 8.03 7.19 10.32 14.41 12.56 21.68 17.47 21.18
Current Ratio
1.04 1.01 1.02 0.99 1.03 0.95 0.92 0.92 0.90 0.85
Net Debt/EBITDA
0.69 1.33 1.18 0.95 (2.29) 3.42 1.51 1.58 1.10 1.10
Debt/Equity
0.76 0.78 0.92 1.39 86.94 (7.31) (8.20) (7.34) (6.64) (6.54)
ROE
50.00% 0.63% 0.37% 13.24% (165.54%) (137.79%) (216.94%) (194.37%) (200.12%) (274.39%)
ROA
8.63% 0.11% 0.06% 1.49% (7.19%) 1.74% 5.67% 4.63% 4.62% 6.05%
ROIC
26.13% 3.12% 4.29% 17.92% (34.57%) 16.38% 45.25% 43.94% 71.41% 66.20%
Return on Tangible Assets
139.75% 2.30% 1.00% 45.85% (117.59%) (779.02%) (239.25%) (144.95%) (88.96%) (66.70%)
Average Days of Receivables
33.49 31.03 31.07 31.52 29.39 25.70 25.60 25.54 26.07 25.32
Earnings Yield
15.89% 0.16% 0.07% 3.84% (14.63%) 2.38% 7.07% 4.20% 3.86% 4.47%
Free Cash Flow Yield
12.76% 12.95% 14.91% 15.83% 12.45% 8.36% 9.16% 5.08% 6.10% 5.06%
Free Cash Flow per Share
18.92 18.10 17.72 21.42 24.29 25.60 32.61 27.23 41.02 43.77
Book value per Share
51.01 48.35 42.22 29.40 1.09 (11.77) (10.56) (12.00) (13.30) (14.38)
Free Cash Flow
4,182.00 3,765.00 3,479.00 3,868.00 3,901.00 3,899.00 4,601.00 3,627.00 5,226.00 5,410.00
EV/EBIT
5.41 45.00 31.54 11.17 0.00 27.57 13.19 20.11 20.65 18.45
Other line items

Show all line items

Columns are period end dates · fundamentals updated 4 Nov 2026